| Year |
Citation |
Score |
| 2020 |
Hu J, Blatchford PJ, Goldenberg NA, Kittelson JM. Group sequential designs for clinical trials with bivariate endpoints. Statistics in Medicine. 39: 3823-3839. PMID 33048360 DOI: 10.1002/Sim.8696 |
0.624 |
|
| 2016 |
Kittelson JM, Steg PG, Halperin JL, Goldenberg NA, Schulman S, Spyropoulos AC, Kessler CM, Turpie AG, Cutler NR, Hiatt WR. Bivariate evaluation of thromboembolism and bleeding in clinical trials of anticoagulants in patients with atrial fibrillation. Thrombosis and Haemostasis. 116. PMID 27346176 DOI: 10.1160/Th15-12-1000 |
0.321 |
|
| 2015 |
Goldenberg NA, Takemoto CM, Yee DL, Kittelson JM, Massicotte MP. Improving evidence on anticoagulant therapies for venous thromboembolism in children: key challenges and opportunities. Blood. 126: 2541-7. PMID 26500341 DOI: 10.1182/Blood-2015-06-651539 |
0.309 |
|
| 2015 |
Goldenberg NA, Abshire T, Blatchford PJ, Fenton LZ, Halperin JL, Hiatt WR, Kessler CM, Kittelson JM, Manco-Johnson MJ, Spyropoulos AC, Steg PG, Stence NV, Turpie AG, Schulman S. Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids-DOTT trial): pilot/feasibility phase findings. Journal of Thrombosis and Haemostasis : Jth. PMID 26118944 DOI: 10.1111/Jth.13038 |
0.626 |
|
| 2014 |
Goldenberg NA, Abshire TC, Halperin JL, Hiatt WR, Kessler CM, Kittelson JM, Manco-Johnson MJ, Spyropoulos A, Steg PG, Turpie AG, Schulman S. Pilot/Feasibility Metrics, Real-Time Remote Monitoring, and Inter-Observer Agreement on Veno-Occlusion in a National Multicenter Randomized Controlled Trial of Pediatric Venous Thromboembolism: Findings from the Pilot/Feasibility Phase of the Kids-DOTT Trial Blood. 124: 4271-4271. DOI: 10.1182/Blood.V124.21.4271.4271 |
0.357 |
|
| 2013 |
Kittelson JM, Spyropoulos AC, Halperin JL, Kessler CM, Schulman S, Steg G, Turpie AG, Cutler NR, Hiatt WR, Goldenberg NA. Balancing risk and benefit in venous thromboembolism trials: concept for a bivariate endpoint trial design and analytic approach. Journal of Thrombosis and Haemostasis : Jth. 11: 1443-8. PMID 23773172 DOI: 10.1111/Jth.12324 |
0.351 |
|
| 2012 |
Boyd AP, Kittelson JM, Gillen DL. Estimation of treatment effect under non-proportional hazards and conditionally independent censoring. Statistics in Medicine. 31: 3504-15. PMID 22763957 DOI: 10.1002/Sim.5440 |
0.663 |
|
| 2011 |
Keith RL, Blatchford PJ, Kittelson J, Minna JD, Kelly K, Massion PP, Franklin WA, Mao J, Wilson DO, Merrick DT, Hirsch FR, Kennedy TC, Bunn PA, Geraci MW, Miller YE. Oral iloprost improves endobronchial dysplasia in former smokers. Cancer Prevention Research (Philadelphia, Pa.). 4: 793-802. PMID 21636546 DOI: 10.1158/1940-6207.Capr-11-0057 |
0.627 |
|
| 2009 |
Berger JS, Krantz MJ, Kittelson JM, Hiatt WR. Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials. Jama. 301: 1909-19. PMID 19436018 DOI: 10.1001/Jama.2009.623 |
0.3 |
|
| 2009 |
Kelly K, Kittelson J, Franklin WA, Kennedy TC, Klein CE, Keith RL, Dempsey EC, Lewis M, Jackson MK, Hirsch FR, Bunn PA, Miller YE. A randomized phase II chemoprevention trial of 13-CIS retinoic acid with or without alpha tocopherol or observation in subjects at high risk for lung cancer. Cancer Prevention Research (Philadelphia, Pa.). 2: 440-9. PMID 19401528 DOI: 10.1158/1940-6207.Capr-08-0136 |
0.329 |
|
| 2007 |
Miller YE, Blatchford P, Hyun DS, Keith RL, Kennedy TC, Wolf H, Byers T, Bunn PA, Lewis MT, Franklin WA, Hirsch FR, Kittelson J. Bronchial epithelial Ki-67 index is related to histology, smoking, and gender, but not lung cancer or chronic obstructive pulmonary disease. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 2425-31. PMID 18006932 DOI: 10.1158/1055-9965.Epi-07-0220 |
0.593 |
|
| 2007 |
Emerson SS, Kittelson JM, Gillen DL. Frequentist evaluation of group sequential clinical trial designs. Statistics in Medicine. 26: 5047-80. PMID 17573678 DOI: 10.1002/Sim.2901 |
0.333 |
|
| 2007 |
Emerson SS, Kittelson JM, Gillen DL. Bayesian evaluation of group sequential clinical trial designs. Statistics in Medicine. 26: 1431-49. PMID 17066402 DOI: 10.1002/Sim.2640 |
0.325 |
|
| 2005 |
Kittelson JM, Sharples K, Emerson SS. Group sequential clinical trials for longitudinal data with analyses using summary statistics. Statistics in Medicine. 24: 2457-75. PMID 15977295 DOI: 10.1002/Sim.2127 |
0.357 |
|
| 2005 |
Keith R, Miller Y, Kelly K, Hirsch F, Kittelson J, Jackson M, Metsinger V, Franklin W, Bunn P, Geraci M. PD-056 Clinical update on the phase II trial of oral iloprost in the chemoprevention of lung cancer in high risk patients Lung Cancer. 49. DOI: 10.1016/S0169-5002(05)80389-7 |
0.314 |
|
| 2004 |
Varella-Garcia M, Kittelson J, Schulte AP, Vu KO, Wolf HJ, Zeng C, Hirsch FR, Byers T, Kennedy T, Miller YE, Keith RL, Franklin WA. Multi-target interphase fluorescence in situ hybridization assay increases sensitivity of sputum cytology as a predictor of lung cancer. Cancer Detection and Prevention. 28: 244-51. PMID 15350627 DOI: 10.1016/J.Cdp.2004.04.007 |
0.301 |
|
| 2003 |
Kelly K, Kittelson J, Lambert-Kerzner A, Hirsch FR, Franklin W, Keith RL, Kennedy TC, Miller YE, Bunn PA. P-277 A histological model to predict airway response to promising chemoprevention agents in phase II lung cancer prevention trials Lung Cancer. 41: S162. DOI: 10.1016/S0169-5002(03)92245-8 |
0.318 |
|
| 1997 |
Emerson SS, Kittelson JM. 13 A unified family of group sequential designs Controlled Clinical Trials. 18: S49. DOI: 10.1016/S0197-2456(97)90998-3 |
0.305 |
|
| Show low-probability matches. |